Viewing Study NCT03777332


Ignite Creation Date: 2025-12-24 @ 9:41 PM
Ignite Modification Date: 2026-01-02 @ 2:04 PM
Study NCT ID: NCT03777332
Status: COMPLETED
Last Update Posted: 2021-11-10
First Post: 2018-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Safety of Intravitreal APL-2 in Patients Diagnosed With Geographic Atrophy
Sponsor: Apellis Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module